Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
6.12B | 6.26B | 6.04B | 5.81B | 4.92B | Gross Profit |
2.32B | 2.35B | 2.43B | 2.43B | 2.11B | EBIT |
7.05M | -1.18B | 225.56M | 266.07M | 194.42M | EBITDA |
7.05M | -971.83M | 407.75M | 452.22M | 352.36M | Net Income Common Stockholders |
-101.82M | -1.28B | 90.80M | 164.42M | -26.48M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
165.76M | 125.43M | 201.90M | 211.60M | 111.40M | Total Assets |
5.19B | 5.36B | 6.61B | 6.50B | 6.08B | Total Debt |
2.94B | 3.04B | 3.13B | 3.05B | 3.00B | Net Debt |
2.77B | 2.92B | 2.93B | 2.84B | 2.89B | Total Liabilities |
4.08B | 4.18B | 4.23B | 4.24B | 4.02B | Stockholders Equity |
1.11B | 1.18B | 2.38B | 2.27B | 2.07B |
Cash Flow | Free Cash Flow | |||
49.68M | -9.88M | 67.98M | 119.11M | 109.06M | Operating Cash Flow |
177.67M | 215.72M | 346.00M | 358.21M | 268.62M | Investing Cash Flow |
-123.90M | -207.44M | -320.32M | -237.08M | -157.19M | Financing Cash Flow |
-8.75M | -85.35M | -33.84M | -18.78M | -146.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $35.90B | 18.61 | 36.48% | 1.50% | 2.04% | -15.61% | |
75 Outperform | $17.10B | 46.67 | 76.24% | ― | 7.64% | 369.79% | |
71 Outperform | $15.35B | 17.76 | 30.21% | 5.24% | -3.23% | -28.11% | |
69 Neutral | $17.11B | 20.25 | 19.19% | 3.37% | 1.99% | -32.18% | |
62 Neutral | $6.90B | 11.05 | 2.80% | 4.27% | 2.67% | -24.92% | |
51 Neutral | $12.77B | 48.01 | 6.62% | ― | -25.30% | 479.26% | |
46 Neutral | $733.74M | ― | -5.90% | ― | -2.37% | 95.07% |
On June 5, 2025, Petco Health and Wellness Company reported its financial results for the first quarter of 2025, revealing a 2.3% decrease in net sales to $1.5 billion compared to the previous year, yet achieving an improved operating income of $16.4 million. Despite a slight decline in comparable sales, the company expanded its gross profit margin and improved its GAAP net loss, while reaffirming its fiscal 2025 net sales and earnings outlook. Petco’s CEO highlighted the company’s strategic focus on strengthening retail fundamentals and achieving sustainable growth, with the current market conditions accelerating these efforts.
The most recent analyst rating on (WOOF) stock is a Hold with a $3.25 price target. To see the full list of analyst forecasts on Petco Health and Wellness Company stock, see the WOOF Stock Forecast page.
On May 19, 2025, Christy Lake resigned from Petco Health and Wellness Company‘s Board of Directors and its compensation committee, effective after the 2025 Annual Meeting of Stockholders. Her resignation was not due to any disagreement with the company. Following her resignation, the Board decided to reduce its size to 10 directors.
The most recent analyst rating on (WOOF) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Petco Health and Wellness Company stock, see the WOOF Stock Forecast page.
Petco Health and Wellness Company reported its financial results for the fourth quarter and full year 2024, showing a decrease in net revenue and gross profit compared to the previous year. Despite these declines, the company reduced its GAAP net loss significantly and improved its free cash flow. CEO Joel Anderson expressed confidence in the new leadership team’s ability to drive double-digit adjusted EBITDA growth in 2025, positioning the company for sustainable profitable growth.